ReviewTranslational gastroenterology and hepatology2025
Enhancing the management of acute and gangrenous cholecystitis: a systematic review supported by the TriNetX database.
Review in Translational gastroenterology and hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Role of Abdominal Contrast-Enhanced Computed Tomography in Diagnosing Gangrenous Gall Bladder Wall Perforation.Cureus · 2026Article
- Development and external validation of a machine learning model for predicting gangrenous cholecystitis.Frontiers in medicine · 2026Article
- Artificial intelligence in gangrenous cholecystitis: advances in risk factor identification and preoperative prediction-a scoping review.Frontiers in surgery · 2026Review
- Predictors of acute gangrenous cholecystitis and its complications: a retrospective cohort study.BMC surgery · 2025Article
- Cholecystectomy in the Context of Cirrhosis, Sclero-Atrophic Cholecystitis, and Gangrenous Cholecystitis: A Literature Review.Medicina (Kaunas, Lithuania) · 2025Review
- Ultrasound-guided percutaneous transhepatic cholecystic puncture and drainage for acute severe cholecystitis-a Case Report.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute cholecystitis (AC) leads to emergency hospital admissions, and is categorized into mild, moderate, or severe grades, and affects hospital stay, surgery rates, costs, and prognosis. Gangrenous cholecystitis (GC) is the severe form and entails gallbladder wall necrosis and infection, possibly leading to emphysematous cholecystitis (EC), a life-threatening variant: early recognition of such a condition is crucial, since its symptoms may mimic uncomplicated AC. The current literature lacks comprehensive reviews on EC and GC due to their rarity and this study aims to bridge this gap by utilizing the TriNetX database, comparing clinical data of AC with GC outcomes. Methods: The study involved data retrieval from PubMed and Medline and the TriNetX database. Initially, 981 English articles were identified, focusing on emphysematous and GC and cholecystectomy. After filtering and reviewing, 73 articles were suitable for inclusion. We analyzed electronic medical records of adults diagnosed with AC, comparing demographics, comorbidities, and medications between medical and surgical intervention groups. Propensity score matching balanced cohorts, and Kaplan-Meier analysis estimated outcomes, while other statistical analyses, including risk ratios (RRs) and odds ratios (ORs), were conducted within TriNetX, with significance set at P<0.05. The study aimed to compare 5-year all-cause mortality in AC patients treated with or without surgery. Results: We found 9 retrospective studies and 3 prospective studies. Additionally, 70 patients from 62 case reports were utilized for descriptive analyses. From the TriNetX database, a total of 245,668 patients hospitalized for AC we identified. Despite, overweight/obesity was more frequent in the surgery group (24% Conclusions: In GC, timely surgical intervention within 72-96 hours reduces complications, such as infections and hospital admissions. Laparoscopic surgery decreases intensive care unit (ICU) admissions and intra-abdominal abscesses. For AC, proton pump inhibitors (PPIs) seem to increase the risk of surgical intervention. In general, surgery is crucial for overall survival in the first 200 days of post-hospitalization. Anyway, confirmation through additional studies is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.